Clinical evaluation of a novel plasma pTau217 electrochemiluminescence immunoassay in Alzheimer’s diseasePia Kivisäkk, Steven E. Arnold|Scientific Reports|2024Cited by 52
Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokersK. N. Rose, Stephen N. Gomperts, Aline Fassini et al.|npj Parkinson s Disease|2024Cited by 20